Literature DB >> 21035074

Toxic anterior segment syndrome after pediatric cataract surgery.

Yusen Huang1, Yunhai Dai, Xiaoming Wu, Jie Lan, Lixin Xie.   

Abstract

Toxic anterior segment syndrome is an acute, sterile, anterior segment inflammation that occurs after any anterior segment surgery. The condition is an increasingly recognized complication of adult cataract surgery. Here we report the clinical findings of a case of toxic anterior segment syndrome in a child after uneventful congenital cataract surgery.
Copyright © 2010 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21035074     DOI： 10.1016/j.jaapos.2010.06.011

Source DB:  PubMed          Journal:  J AAPOS        ISSN： 1091-8531            Impact factor:   1.220


  5 in total

1.  Toxic anterior segment syndrome - A sequel of uneventful cataract surgery.

Authors:  P S Moulick; Sridhara Reddy; V S Gurunadh; V K Mohindra
Journal:  Med J Armed Forces India       Date:  2014-04-03

2.  The role of patient's systemic characteristics and plateletcrit in developing toxic anterior segment syndrome after uneventful phaco surgery: A case-control study.

Authors:  Serpil Yazgan; Ugur Celik; Orhan Ayar; Suat Hayri Ugurbas; Burcu Celik; Mehmet Orçun Akdemir; Silay Canturk Ugurbas; Atilla Alpay
Journal:  Int Ophthalmol       Date:  2017-01-27       Impact factor: 2.031

3.  Toxic anterior segment syndrome after pediatric cataract surgery.

Authors:  Scott R Lambert
Journal:  J AAPOS       Date:  2010-09-21       Impact factor: 1.220

Review 4.  Pediatric cataract: challenges and future directions.

Authors:  Anagha Medsinge; Ken K Nischal
Journal:  Clin Ophthalmol       Date:  2015-01-07

5.  Ocular hypertension after pediatric cataract surgery: baseline characteristics and first-year report.

Authors:  Haotian Lin; Weirong Chen; Lixia Luo; Xinyu Zhang; Jingjing Chen; Zhuoling Lin; Bo Qu; Jiao Zhan; Danying Zheng; Xiaojian Zhong; Zhen Tian; Yizhi Liu
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.